{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:06Z","timestamp":1786982166196,"version":"build-2736575974"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12010-018-2724-4","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T20:50:46Z","timestamp":1520283046000},"page":"85-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ligand-Based Pharmacophore Screening Strategy: a Pragmatic Approach for Targeting HER Proteins"],"prefix":"10.1007","volume":"186","author":[{"given":"Nivya","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-0729","authenticated-orcid":false,"given":"K.","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"2724_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","volume":"79","author":"R Roskoski","year":"2014","unstructured":"Roskoski, R. (2014). The ErbB\/HER family of protein-tyrosine kinases and cancer. Pharmacological Research, 79, 34\u201374.","journal-title":"Pharmacological Research"},{"issue":"10","key":"2724_CR2","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","volume":"65","author":"MJ Wieduwilt","year":"2008","unstructured":"Wieduwilt, M. J., & Moasser, M. M. (2008). The epidermal growth factor receptor family: biology driving targeted therapeutics. Cellular and Molecular Life Sciences, 65(10), 1566\u20131584.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"4","key":"2724_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.bjc.6603910","volume":"97","author":"AA Hsieh","year":"2007","unstructured":"Hsieh, A. A., & Moasser, M. M. (2007). Targeting HER proteins in cancer therapy and the role of the non-target HER3. British Journal of Cancer, 97(4), 453\u2013457.","journal-title":"British Journal of Cancer"},{"key":"2724_CR4","unstructured":"Cappuzzo, F. (2014). The human epidermal growth factor receptor (HER) family: structure and function. In Guide to targeted therapies: EGFR mutations in NSCLC (pp. 7\u201317)."},{"issue":"1","key":"2724_CR5","first-page":"36","volume":"4","author":"BA Chan","year":"2015","unstructured":"Chan, B. A., & Hughes, B. G. (2015). Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Translational lung cancer research, 4(1), 36\u201354.","journal-title":"Translational lung cancer research"},{"issue":"18","key":"2724_CR6","first-page":"4968","volume":"49","author":"PM Schneider","year":"1989","unstructured":"Schneider, P. M., Hung, M. C., Chiocca, S. M., Manning, J., Zhao, X., Fang, K., & Roth, J. A. (1989). Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Research, 49(18), 4968\u20134971.","journal-title":"Cancer Research"},{"issue":"9","key":"2724_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/sj.bjc.6600286","volume":"86","author":"FR Hirsch","year":"2002","unstructured":"Hirsch, F. R., Varella-Garcia, M., Franklin, W. A., Veve, R., Chen, L., Helfrich, B., Zeng, C., Baron, A., & Bunn, P. A. (2002). Evaluation of HER-2\/neu gene amplification and protein expression in non-small cell lung carcinomas. British Journal of Cancer, 86(9), 1449\u20131456.","journal-title":"British Journal of Cancer"},{"issue":"10","key":"2724_CR8","first-page":"3645","volume":"9","author":"C Pellegrini","year":"2003","unstructured":"Pellegrini, C., Falleni, M., Marchetti, A., Cassani, B., Miozzo, M., Buttitta, F., Roncalli, M., Coggi, G., & Bosari, S. (2003). HER-2\/neu alterations in non-small cell lung cancer. Clinical Cancer Research, 9(10), 3645\u20133652.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"2724_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.lungcan.2014.12.018","volume":"87","author":"N Mar","year":"2015","unstructured":"Mar, N., Vredenburgh, J. J., & Wasser, J. S. (2015). Targeting HER2 in the treatment of non-small cell lung cancer. Lung Cancer, 87(3), 220\u2013225.","journal-title":"Lung Cancer"},{"issue":"1","key":"2724_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0014-4827(02)00101-5","volume":"284","author":"A Citri","year":"2003","unstructured":"Citri, A., Skaria, K. B., & Yarden, Y. (2003). The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Experimental Cell Research, 284(1), 54\u201365.","journal-title":"Experimental Cell Research"},{"issue":"7","key":"2724_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","volume":"16","author":"D Graus-Porta","year":"1997","unstructured":"Graus-Porta, D., Beerli, R. R., Daly, J. M., & Hynes, N. E. (1997). ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. The EMBO Journal, 16(7), 1647\u20131655.","journal-title":"The EMBO Journal"},{"issue":"2","key":"2724_CR12","first-page":"142","volume":"10","author":"ES Yi","year":"1997","unstructured":"Yi, E. S., Harclerode, D., Gondo, M., Stephenson, M., Brown, R. W., Younes, M., & Cagle, P. T. (1997). High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc, 10(2), 142\u2013148.","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"2","key":"2724_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.lungcan.2007.03.009","volume":"57","author":"AV Koutsopoulos","year":"2007","unstructured":"Koutsopoulos, A. V., Mavroudis, D., Dambaki, K. I., Souglakos, J., Tzortzaki, E. G., Drositis, J., Delides, G. S., Georgoulias, V., & Stathopoulos, E. N. (2007). Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome. Lung Cancer, 57(2), 193\u2013200.","journal-title":"Lung Cancer"},{"issue":"9","key":"2724_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.tcb.2006.07.003","volume":"16","author":"J Boudeau","year":"2006","unstructured":"Boudeau, J., Miranda-Saavedra, D., Barton, G. J., & Alessi, D. R. (2006). Emerging roles of pseudokinases. Trends in Cell Biology, 16(9), 443\u2013452.","journal-title":"Trends in Cell Biology"},{"issue":"17","key":"2724_CR15","doi-asserted-by":"publisher","first-page":"7692","DOI":"10.1073\/pnas.1002753107","volume":"107","author":"F Shi","year":"2010","unstructured":"Shi, F., Telesco, S. E., Liu, Y., Radhakrishnan, R., & Lemmon, M. A. (2010). ErbB3\/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proceedings of the National Academy of Sciences, 107(17), 7692\u20137697.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"2724_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1476-4598-13-105","volume":"13","author":"J Ma","year":"2014","unstructured":"Ma, J., Lyu, H., Huang, J., & Liu, B. (2014). Targeting of erbB3 receptor to overcome resistance in cancer treatment. Molecular Cancer, 13(1), 105.","journal-title":"Molecular Cancer"},{"issue":"1","key":"2724_CR17","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/msb4100012","volume":"1","author":"WX Schulze","year":"2005","unstructured":"Schulze, W. X., Deng, L., & Mann, M. (2005). Phosphotyrosine interactome of the ErbB-receptor kinase family. Molecular Systems Biology, 1(1), E1\u2013E13.","journal-title":"Molecular Systems Biology"},{"issue":"3","key":"2724_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7","volume":"185","author":"R Srinivasan","year":"1998","unstructured":"Srinivasan, R., Poulsom, R., Hurst, H. C., & Gullick, W. J. (1998). Expression of the c-erbB-4\/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. The Journal of Pathology, 185(3), 236\u2013245.","journal-title":"The Journal of Pathology"},{"issue":"1A","key":"2724_CR19","first-page":"481","volume":"19","author":"AE Moustafa Al","year":"1999","unstructured":"Al Moustafa, A. E., Alaoui-Jamali, M., Paterson, J., & O'Connor-McCourt, M. (1999). Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines. Anticancer Research, 19(1A), 481\u2013486.","journal-title":"Anticancer Research"},{"issue":"2","key":"2724_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ijc.21818","volume":"119","author":"A Starr","year":"2006","unstructured":"Starr, A., Greif, J., Vexler, A., Ashkenazy-Voghera, M., Gladesh, V., Rubin, C., Kerber, G., Marmor, S., Lev-Ari, S., Inbar, M., & Yarden, Y. (2006). ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. International Journal of Cancer, 119(2), 269\u2013274.","journal-title":"International Journal of Cancer"},{"issue":"3","key":"2724_CR21","first-page":"99","volume":"9","author":"S Lejeune","year":"2015","unstructured":"Lejeune, S., & Machiels, J. P. (2015). Pan-HER inhibitors. Belgian Journal of Medical Oncology, 9(3), 99\u2013103.","journal-title":"Belgian Journal of Medical Oncology"},{"key":"2724_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fonc.2015.00002","volume":"5","author":"X Wang","year":"2015","unstructured":"Wang, X., Batty, K. M., Crowe, P. J., Goldstein, D., & Yang, J. L. (2015). The potential of panHER inhibition in cancer. Frontiers in Oncology, 5, 2.","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"2724_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12010-015-1760-6","volume":"177","author":"B Preethi","year":"2015","unstructured":"Preethi, B., Shanthi, V., & Ramanathan, K. (2015). Investigation of nalidixic acid resistance mechanism in Salmonella enterica using molecular simulation techniques. Applied Biochemistry and Biotechnology, 177(2), 528\u2013540.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"2","key":"2724_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12010-012-9687-7","volume":"167","author":"V Karthick","year":"2012","unstructured":"Karthick, V., Shanthi, V., Rajasekaran, R., & Ramanathan, K. (2012). Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach. Applied Biochemistry and Biotechnology, 167(2), 237\u2013249.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"1","key":"2724_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334\u2013395.","journal-title":"Pharmacological Reviews"},{"key":"2724_CR26","unstructured":"James, N., & Ramanathan, K. (2017). Discovery of potent ALK inhibitors using pharmacophore-informatics strategy. Cell Biochemistry and Biophysics, 1\u201314."},{"key":"2724_CR27","unstructured":"Rohini, K., & Shanthi, V. (2017) Discovery of potent neuraminidase inhibitors using a combination of pharmacophore-based virtual screening and molecular simulation approach. Applied Biochemistry and Biotechnology, 1\u201320."},{"key":"2724_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jmgm.2011.07.004","volume":"30","author":"KH Dhanachandra Singh","year":"2011","unstructured":"Dhanachandra Singh, K. H., Karthikeyan, M., Kirubakaran, P., & Nagamani, S. (2011). Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors. Journal of Molecular Graphics & Modelling, 30, 186\u2013197.","journal-title":"Journal of Molecular Graphics & Modelling"},{"issue":"2","key":"2724_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11030-011-9349-7","volume":"16","author":"RC Dash","year":"2012","unstructured":"Dash, R. C., Bhosale, S. H., Shelke, S. M., Suryawanshi, M. R., Kanhed, A. M., & Mahadik, K. R. (2012). Scaffold hopping for identification of novel D 2 antagonist based on 3D pharmacophore modelling of illoperidone analogs. Molecular Diversity, 16(2), 367\u2013375.","journal-title":"Molecular Diversity"},{"issue":"6","key":"2724_CR30","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s12010-015-1672-5","volume":"176","author":"AS Pinheiro","year":"2015","unstructured":"Pinheiro, A. S., Duarte, J. B. C., Alves, C. N., & de Molfetta, F. A. (2015). Virtual screening and molecular dynamics simulations from a bank of molecules of the amazon region against functional NS3-4A protease-helicase enzyme of hepatitis C virus. Applied Biochemistry and Biotechnology, 176(6), 1709\u20131721.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"4","key":"2724_CR31","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s12010-013-0615-2","volume":"172","author":"JY Joung","year":"2014","unstructured":"Joung, J. Y., Lee, H. Y., Park, J., Lee, J. Y., Chang, B. H., No, K. T., Nam, K. Y., & Hwang, J. S. (2014). Identification of novel rab27a\/melanophilin blockers by pharmacophore-based virtual screening. Applied Biochemistry and Biotechnology, 172(4), 1882\u20131897.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"7","key":"2724_CR32","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1007\/s12010-012-9897-z","volume":"168","author":"VK Morya","year":"2012","unstructured":"Morya, V. K., Dewaker, V., & Kim, E. K. (2012). In silico study and validation of phosphotransacetylase (PTA) as a putative drug target for Staphylococcus aureus by homology-based modelling and virtual screening. Applied Biochemistry and Biotechnology, 168(7), 1792\u20131805.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2724_CR33","doi-asserted-by":"crossref","unstructured":"Ramatenki, V., Dumpati, R., Vadija, R., Vellanki, S., Potlapally, S.R., Rondla, R., & Vuruputuri, U. (2017). Identification of new lead molecules against UBE2NL enzyme for cancer therapy. Applied Biochemistry and Biotechnology, 1\u201321.","DOI":"10.1007\/s12010-017-2414-7"},{"issue":"2","key":"2724_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10799893.2014.942461","volume":"35","author":"A Sudha","year":"2015","unstructured":"Sudha, A., Srinivasan, P., & Rameshthangam, P. (2015). Exploration of potential EGFR inhibitors: a combination of pharmacophore-based virtual screening, atom-based 3D-QSAR and molecular docking analysis. Journal of Receptors and Signal Transduction, 35(2), 137\u2013148.","journal-title":"Journal of Receptors and Signal Transduction"},{"key":"2724_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jtbi.2016.09.016","volume":"411","author":"D Gogoi","year":"2016","unstructured":"Gogoi, D., Baruah, V. J., Chaliha, A. K., Kakoti, B. B., Sarma, D., & Buragohain, A. K. (2016). 3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors. Journal of Theoretical Biology, 411, 68\u201380.","journal-title":"Journal of Theoretical Biology"},{"issue":"1","key":"2724_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235\u2013242.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"2724_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1742-4658.2007.06178.x","volume":"275","author":"A Wlodawer","year":"2008","unstructured":"Wlodawer, A., Minor, W., Dauter, Z., & Jaskolski, M. (2008). Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. The FEBS Journal, 275(1), 1\u201321.","journal-title":"The FEBS Journal"},{"issue":"3","key":"2724_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1107\/S0907444999016364","volume":"56","author":"GJ Kleywegt","year":"2000","unstructured":"Kleywegt, G. J. (2000). Validation of protein crystal structures. Acta Crystallographica Section D: Biological Crystallography, 56(3), 249\u2013265.","journal-title":"Acta Crystallographica Section D: Biological Crystallography"},{"key":"2724_CR39","unstructured":"Pilotto, S., Rossi, A., Vaval\u00e0, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., & Piovano, P. L. (2017). Outcomes of first-generation EGFR-TKIs against non-small-cell lung cancer harboring uncommon EGFR mutations: a post-hoc analysis of the BE-POSITIVE study. Clinical Lung Cancer."},{"issue":"2","key":"2724_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.6004\/jnccn.2013.0024","volume":"11","author":"AY Helena","year":"2013","unstructured":"Helena, A. Y., & Riely, G. J. (2013). Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in lung cancers. Journal of the National Comprehensive Cancer Network, 11(2), 161\u2013169.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"10","key":"2724_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1021\/ml4002437","volume":"4","author":"J Wu","year":"2013","unstructured":"Wu, J., Chen, W., Xia, G., Zhang, J., Shao, J., Tan, B., Zhang, C., Yu, W., Weng, Q., Liu, H., & Hu, M. (2013). Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting EGFR. ACS Medicinal Chemistry Letters, 4(10), 974\u2013978.","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"D1","key":"2724_CR42","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2013","unstructured":"Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., & Tang, A. (2013). DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Research, 42(D1), D1091\u2013D1097.","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"2724_CR43","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/ci000150t","volume":"41","author":"JH Voigt","year":"2001","unstructured":"Voigt, J. H., Bienfait, B., Wang, S., & Nicklaus, M. C. (2001). Comparison of the NCI open database with seven large chemical structural databases. Journal of Chemical Information and Computer Sciences, 41(3), 702\u2013712.","journal-title":"Journal of Chemical Information and Computer Sciences"},{"issue":"1","key":"2724_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J., & Shoichet, B. K. (2005). ZINC\u2014a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177\u2013182.","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"2","key":"2724_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/bib\/bbv037","volume":"17","author":"E Glaab","year":"2015","unstructured":"Glaab, E. (2015). Building a virtual ligand screening pipeline using free software: a survey. Briefings in Bioinformatics, 17(2), 352\u2013366.","journal-title":"Briefings in Bioinformatics"},{"issue":"12","key":"2724_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: a software program for pKa prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681\u2013691.","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"12","key":"2724_CR47","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1021\/ci900364w","volume":"49","author":"T Kalliokoski","year":"2009","unstructured":"Kalliokoski, T., Salo, H. S., Lahtela-Kakkonen, M., & Poso, A. (2009). The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening. Journal of Chemical Information and Modeling, 49(12), 2742\u20132748.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"2724_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compbiolchem.2013.10.005","volume":"48","author":"OG Yilmaz","year":"2014","unstructured":"Yilmaz, O. G., Olmez, E. O., & Ulgen, K. O. (2014). Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening. Computational Biology and Chemistry, 48, 1\u201313.","journal-title":"Computational Biology and Chemistry"},{"issue":"6","key":"2724_CR49","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1021\/ci900501c","volume":"50","author":"F Milletti","year":"2010","unstructured":"Milletti, F., & Vulpetti, A. (2010). Tautomer preference in PDB complexes and its impact on structure-based drug discovery. Journal of Chemical Information and Modeling, 50(6), 1062\u20131074.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"2724_CR50","doi-asserted-by":"publisher","unstructured":"Khan, M. F., Verma, G., Akhtar, W., Shaquiquzzaman, M., Akhter, M., Rizvi, M. A., & Alam, M. M. (2016). Pharmacophore modeling, 3D-QSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents. Arabian Journal of Chemistry. \n                    https:\/\/doi.org\/10.1016\/j.arabjc.2016.11.004\n                    \n                  .","DOI":"10.1016\/j.arabjc.2016.11.004"},{"issue":"5","key":"2724_CR51","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s00044-013-0842-7","volume":"23","author":"AR Muralidharan","year":"2014","unstructured":"Muralidharan, A. R., Selvaraj, C., Singh, S., Nelson Jesudasan, C. A., Geraldine, P., & Thomas, P. (2014). Virtual screening based on pharmacophoric features of known calpain inhibitors to identify potent inhibitors of calpain. Medicinal Chemistry Research: An International Journal for Rapid Communications on Design And Mechanisms of Action of Biologically Active Agents, 23(5), 2445\u20132455.","journal-title":"Medicinal Chemistry Research: An International Journal for Rapid Communications on Design And Mechanisms of Action of Biologically Active Agents"},{"issue":"10-11","key":"2724_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design., 20(10-11), 647\u2013671.","journal-title":"Journal of Computer-Aided Molecular Design."},{"issue":"6","key":"2724_CR53","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1021\/acs.jcim.7b00048","volume":"57","author":"J Ash","year":"2017","unstructured":"Ash, J., & Fourches, D. (2017). Characterizing the chemical space of ERK2 kinase inhibitors using descriptors computed from molecular dynamics trajectories. Journal of chemical information and modelling, 57(6), 1286\u20131299.","journal-title":"Journal of chemical information and modelling"},{"issue":"12","key":"2724_CR54","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1007\/s00253-015-7268-8","volume":"100","author":"VS Rajput","year":"2016","unstructured":"Rajput, V. S., Mehra, R., Kumar, S., Nargotra, A., Singh, P. P., & Khan, I. A. (2016). Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis. Applied Microbiology and Biotechnology, 100(12), 5415\u20135426.","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"4","key":"2724_CR55","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/ci100015j","volume":"50","author":"KS Watts","year":"2010","unstructured":"Watts, K. S., Dalal, P., Murphy, R. B., Sherman, W., Friesner, R. A., & Shelley, J. C. (2010). ConfGen: a conformational search method for efficient generation of bioactive conformers. Journal of Chemical Information and Modeling, 50(4), 534\u2013546.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"2724_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bcp.2016.01.008","volume":"104","author":"F Falco De","year":"2016","unstructured":"De Falco, F., Di Giovanni, C., Cerchia, C., De Stefano, D., Capuozzo, A., Irace, C., Iuvone, T., Santamaria, R., Carnuccio, R., & Lavecchia, A. (2016). Novel non-peptide small molecules preventing IKK\u00df\/NEMO association inhibit NF-\u03baB activation in LPS-stimulated J774 macrophages. Biochemical Pharmacology, 104, 83\u201394.","journal-title":"Biochemical Pharmacology"},{"issue":"16","key":"2724_CR57","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E Lionta","year":"2014","unstructured":"Lionta, E., Spyrou, G., Vassilatis, D. K., & Cournia, Z. (2014). Structure-based virtual screening for drug discovery: principles, applications and recent advances. Current Topics in Medicinal Chemistry, 14(16), 1923\u20131938.","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"7","key":"2724_CR58","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10822-012-9578-6","volume":"26","author":"M Vass","year":"2012","unstructured":"Vass, M., Tarcsay, \u00c1., & Keser\u0171, G. M. (2012). Multiple ligand docking by Glide: implications for virtual second-site screening. Journal of computer-aided molecular design., 26(7), 821\u2013834.","journal-title":"Journal of computer-aided molecular design."},{"issue":"3","key":"2724_CR59","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221\u2013234.","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"7","key":"2724_CR60","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750\u20131759.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"4","key":"2724_CR61","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00044-016-1504-3","volume":"25","author":"R Elancheran","year":"2016","unstructured":"Elancheran, R., Saravanan, K., Choudhury, B., Divakar, S., Kabilan, S., Ramanathan, M., Das, B., Devi, R., & Kotoky, J. (2016). Design and development of oxobenzimidazoles as novel androgen receptor antagonists. Medicinal Chemistry Research., 25(4), 539\u2013552.","journal-title":"Medicinal Chemistry Research."},{"key":"2724_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejmech.2015.12.044","volume":"109","author":"A Capua Di","year":"2016","unstructured":"Di Capua, A., Sticozzi, C., Brogi, S., Brindisi, M., Cappelli, A., Sautebin, L., Rossi, A., Pace, S., Ghelardini, C., Mannelli, L. D. C., & Valacchi, G. (2016). Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity. European Journal of Medicinal Chemistry, 109, 99\u2013106.","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"2","key":"2724_CR63","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/138620710790596736","volume":"13","author":"J McKim","year":"2010","unstructured":"McKim, J., & James, M. (2010). Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Combinatorial Chemistry & High Throughput Screening, 13(2), 188\u2013206.","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"issue":"4","key":"2724_CR64","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1017\/S0033583515000190","volume":"48","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Xing, J., Xu, Y., Zhou, N., Peng, J., Xiong, Z., Liu, X., Luo, X., Luo, C., Chen, K., & Zheng, M. (2015). In silico ADME\/T modelling for rational drug design. Quarterly Reviews of Biophysics, 48(4), 488\u2013515.","journal-title":"Quarterly Reviews of Biophysics"},{"issue":"3","key":"2724_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","volume":"54","author":"WL Jorgensen","year":"2002","unstructured":"Jorgensen, W. L., & Duffy, E. M. (2002). Prediction of drug solubility from structure. Advanced Drug Delivery Reviews, 54(3), 355\u2013366.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"8","key":"2724_CR66","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jmgm.2010.03.010","volume":"28","author":"S Vilar","year":"2010","unstructured":"Vilar, S., Chakrabarti, M., & Costanzi, S. (2010). Prediction of passive blood\u2013brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. Journal of Molecular Graphics and Modelling, 28(8), 899\u2013903.","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"1","key":"2724_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/2193-1801-2-353","volume":"2","author":"F Ntie-Kang","year":"2013","unstructured":"Ntie-Kang, F. (2013). An in silico evaluation of the ADMET profile of the StreptomeDB database. SpringerPlus, 2(1), 353.","journal-title":"SpringerPlus"},{"issue":"2","key":"2724_CR68","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1021\/ci030304f","volume":"44","author":"H Sun","year":"2004","unstructured":"Sun, H. (2004). A universal molecular descriptor system for prediction of logP, logS, logBB, and absorption. Journal of Chemical Information and Computer Sciences, 44(2), 748\u2013757.","journal-title":"Journal of Chemical Information and Computer Sciences"},{"key":"2724_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.molstruc.2016.05.086","volume":"1122","author":"R Malik","year":"2016","unstructured":"Malik, R., Bunkar, D., Choudhary, B. S., Srivastava, S., Mehta, P., & Sharma, M. (2016). High throughput virtual screening and in silico ADMET analysis for rapid and efficient identification of potential PAP 248-286 aggregation inhibitors as anti-HIV agents. Journal of Molecular Structure, 1122, 239\u2013246.","journal-title":"Journal of Molecular Structure"},{"issue":"1","key":"2724_CR70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1747-0285.2012.01329.x","volume":"80","author":"N Chauhan","year":"2012","unstructured":"Chauhan, N., Vidyarthi, A. S., & Poddar, R. (2012). Comparative analysis of different DNA-binding drugs for Leishmaniasis cure: a pharmacoinformatics approach. Chemical Biology & Drug Design, 80(1), 54\u201363.","journal-title":"Chemical Biology & Drug Design"},{"key":"2724_CR71","unstructured":"Chung, T. D., Terry, D. B., & Smith, L. H. (2015). In vitro and in vivo assessment of ADME and PK properties during lead selection and lead optimization\u2014guidelines, benchmarks and rules of thumb."},{"issue":"3","key":"2724_CR72","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00894-014-2099-6","volume":"20","author":"S Goyal","year":"2014","unstructured":"Goyal, S., Grover, S., Dhanjal, J. K., Goyal, M., Tyagi, C., Chacko, S., & Grover, A. (2014). Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis. Journal of Molecular Modeling, 20(3), 2099.","journal-title":"Journal of Molecular Modeling"},{"issue":"7","key":"2724_CR73","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s11051-014-2512-1","volume":"16","author":"F Ramezani","year":"2014","unstructured":"Ramezani, F., Amanlou, M., & Rafii-Tabar, H. (2014). Gold nanoparticle shape effects on human serum albumin corona interface: a molecular dynamic study. Journal of Nanoparticle Research, 16(7), 2512.","journal-title":"Journal of Nanoparticle Research"},{"issue":"Pt 8","key":"2724_CR74","first-page":"1355","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf, A. W., & Van Aalten, D. M. F. (2004). PRODRG\u2014a tool for highthroughput crystallography of protein\u2013ligand complexes. Acta Crystallographica, 60(Pt 8), 1355\u20131363.","journal-title":"Acta Crystallographica"},{"issue":"1","key":"2724_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00709-012-0394-6","volume":"250","author":"V Karthick","year":"2013","unstructured":"Karthick, V., Shanthi, V., Rajasekaran, R., & Ramanathan, K. (2013). In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir. Protoplasma, 250(1), 197\u2013207.","journal-title":"Protoplasma"},{"issue":"4","key":"2724_CR76","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3109\/14756366.2011.603128","volume":"27","author":"MK Teli","year":"2012","unstructured":"Teli, M. K., & Rajanikant, G. K. (2012). Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(4), 558\u2013570.","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"issue":"32","key":"2724_CR77","doi-asserted-by":"publisher","first-page":"33602","DOI":"10.18632\/oncotarget.5286","volume":"6","author":"K Yonesaka","year":"2015","unstructured":"Yonesaka, K., Kudo, K., Nishida, S., Takahama, T., Iwasa, T., Yoshida, T., Tanaka, K., Takeda, M., Kaneda, H., Okamoto, I., & Nishio, K. (2015). The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer. Oncotarget, 6(32), 33602\u201333611.","journal-title":"Oncotarget"},{"issue":"12","key":"2724_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/ijms17020246","volume":"17","author":"W Zhou","year":"2016","unstructured":"Zhou, W., Wang, Y., Lu, A., & Zhang, G. (2016). Systems pharmacology in small molecular drug discovery. International Journal of Molecular Sciences, 17(12), 246.","journal-title":"International Journal of Molecular Sciences"},{"issue":"15","key":"2724_CR79","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1158\/1078-0432.CCR-08-2921","volume":"15","author":"M Sun","year":"2009","unstructured":"Sun, M., Behrens, C., Feng, L., Ozburn, N., Tang, X., Yin, G., Komaki, R., Varella-Garcia, M., Hong, W. K., Aldape, K. D., & Wistuba, I. I. (2009). HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clinical Cancer Research, 15(15), 4829\u20134837.","journal-title":"Clinical Cancer Research"},{"key":"2724_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.compbiolchem.2016.03.006","volume":"62","author":"V Ramar","year":"2016","unstructured":"Ramar, V., & Pappu, S. (2016). Exploring the inhibitory potential of bioactive compound from Luffa acutangula against NF-\u03baB\u2014a molecular docking and dynamics approach. Computational Biology and Chemistry, 62, 29\u201335.","journal-title":"Computational Biology and Chemistry"},{"issue":"3","key":"2724_CR81","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","volume":"11","author":"CH Yun","year":"2007","unstructured":"Yun, C. H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007). Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell, 11(3), 217\u2013227.","journal-title":"Cancer Cell"},{"issue":"5","key":"2724_CR82","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1021\/cb300729y","volume":"8","author":"R Urich","year":"2013","unstructured":"Urich, R., Wishart, G., Kiczun, M., Richters, A., Tidten-Luksch, N., Rauh, D., Sherborne, B., Wyatt, P. G., & Brenk, R. (2013). De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments. ACS Chemical Biology, 8(5), 1044\u20131052.","journal-title":"ACS Chemical Biology"},{"issue":"21","key":"2724_CR83","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","volume":"286","author":"K Aertgeerts","year":"2011","unstructured":"Aertgeerts, K., Skene, R., Yano, J., Sang, B. C., Zou, H., Snell, G., Jennings, A., Iwamoto, K., Habuka, N., Hirokawa, A., & Ishikawa, T. (2011). Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. Journal of Biological Chemistry, 286(21), 18756\u201318765.","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"2724_CR84","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/med.20070","volume":"26","author":"S Kamath","year":"2006","unstructured":"Kamath, S., & Buolamwini, J. K. (2006). Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development. Medicinal Research Reviews, 26(5), 569\u2013594.","journal-title":"Medicinal Research Reviews"},{"issue":"1","key":"2724_CR85","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1021\/jm9503613","volume":"39","author":"AJ Bridges","year":"1996","unstructured":"Bridges, A. J., Zhou, H., Cody, D. R., Rewcastle, G. W., McMichael, A., Showalter, H. H., Fry, D. W., Kraker, A. J., & Denny, W. A. (1996). Tyrosine kinase inhibitors. 8. An unusually steep structure\u2013activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. Journal of Medicinal Chemistry, 39(1), 267\u2013276.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"2724_CR86","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150226","volume":"36","author":"HM Hammar\u00e9n","year":"2016","unstructured":"Hammar\u00e9n, H. M., Virtanen, A. T., & Silvennoinen, O. (2016). Nucleotide-binding mechanisms in pseudokinases. Bioscience Reports, 36(1), e00282.","journal-title":"Bioscience Reports"},{"issue":"51","key":"2724_CR87","doi-asserted-by":"publisher","first-page":"21608","DOI":"10.1073\/pnas.0912101106","volume":"106","author":"N Jura","year":"2009","unstructured":"Jura, N., Shan, Y., Cao, X., Shaw, D. E., & Kuriyan, J. (2009). Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proceedings of the National Academy of Sciences, 106(51), 21608\u201321613.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9","key":"2724_CR88","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s00044-017-1901-2","volume":"26","author":"CL Dong","year":"2017","unstructured":"Dong, C. L., Guo, F. C., & Xue, J. (2017). Computational insights into HER3 gatekeeper T768I resistance mutation to bosutinib in HER3-related breast cancer. Medicinal Chemistry Research, 26(9), 1926\u20131934.","journal-title":"Medicinal Chemistry Research"},{"issue":"5","key":"2724_CR89","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/10799893.2017.1342129","volume":"37","author":"A Sahu","year":"2017","unstructured":"Sahu, A., Patra, P. K., Yadav, M. K., & Varma, M. (2017). Identification and characterization of ErbB4 kinase inhibitors for effective breast cancer therapy. Journal of Receptors and Signal Transduction, 37(5), 470\u2013480.","journal-title":"Journal of Receptors and Signal Transduction"},{"issue":"10","key":"2724_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001680","volume":"11","author":"HS Meharena","year":"2013","unstructured":"Meharena, H. S., Chang, P., Keshwani, M. M., Oruganty, K., Nene, A. K., Kannan, N., Taylor, S. S., & Kornev, A. P. (2013). Deciphering the structural basis of eukaryotic protein kinase regulation. PLoS Biology, 11(10), e1001680.","journal-title":"PLoS Biology"},{"key":"2724_CR91","unstructured":"Ghorab, M. M., & Alsaid, M. S. (2016). Anticancer activity of some novel thieno [2, 3-d] pyrimidine derivatives. Biomedical Research, 27(1)."},{"issue":"2","key":"2724_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.fjps.2015.09.001","volume":"1","author":"EZ Elrazaz","year":"2015","unstructured":"Elrazaz, E. Z., Serya, R. A., Ismail, N. S., El Ella, D. A. A., & Abouzid, K. A. (2015). Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents. Future Journal of Pharmaceutical Sciences, 1(2), 33\u201341.","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"20","key":"2724_CR93","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.1021\/jm100607r","volume":"53","author":"CH Wu","year":"2010","unstructured":"Wu, C. H., Coumar, M. S., Chu, C. Y., Lin, W. H., Chen, Y. R., Chen, C. T., Shiao, H. Y., Rafi, S., Wang, S. Y., Hsu, H., & Chen, C. H. (2010). Design and synthesis of tetrahydropyridothieno [2, 3-d] pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and Michael acceptor group for maximal potency. Journal of Medicinal Chemistry, 53(20), 7316\u20137326.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"2724_CR94","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.bmcl.2008.12.011","volume":"19","author":"TR Rheault","year":"2009","unstructured":"Rheault, T. R., Caferro, T. R., Dickerson, S. H., Donaldson, K. H., Gaul, M. D., Goetz, A. S., Mullin, R. J., McDonald, O. B., Petrov, K. G., Rusnak, D. W., & Shewchuk, L. M. (2009). Thienopyrimidine-based dual EGFR\/ErbB-2 inhibitors. Bioorganic & Medicinal Chemistry Letters, 19(3), 817\u2013820.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"2","key":"2724_CR95","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1021\/jm00152a006","volume":"29","author":"S Agrawal","year":"1986","unstructured":"Agrawal, S., Singh, N. K., Aggarwal, R. C., Sodhi, A., & Tandon, P. (1986). Synthesis, structure, and antitumor activity of N-salicyloyl-N'-(2-furylthiocarbonyl) hydrazine and its copper (II) complex. Journal of Medicinal Chemistry, 29(2), 199\u2013202.","journal-title":"Journal of Medicinal Chemistry"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-018-2724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-018-2724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-018-2724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T22:08:55Z","timestamp":1551823735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-018-2724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2724"],"URL":"https:\/\/doi.org\/10.1007\/s12010-018-2724-4","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]},"assertion":[{"value":"20 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}